RDY Announces Health Canada Approval for Generic Semaglutide Injection in Canada, First Company to Receive Market Authorization, Launch Preparations Underway, GLP-1 Market Expansion, 3.9M Diabetics in Canada, 6% Prediabetes, In-House API Production, OneSource Manufacturing Partne
Dr. Reddy's Laboratories Limited American Depositary Shares · Now $13.63
-3.6% in 7d after detection
Post-detection moves
1h
—
1d
-0.7%
3d
-2.8%
7d
-3.6%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS